Dipeptidase‑2 is a prognostic marker in lung adenocarcinoma that is correlated with its sensitivity to cisplatin-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dipeptidase‑2 is a prognostic marker in lung adenocarcinoma that is correlated with its sensitivity to cisplatin

Published:2023-07-11 Issue:2 Volume:50 Page:
ISSN:1021-335X
Container-title:Oncology Reports
language:
Short-container-title:Oncol Rep

Author:

Wang Yuanyi¹,Zhang Ting¹,Du Hongfei²,Yang Min¹,Xie Guangsu³,Liu Teng¹,Deng Shihua¹,Yuan Wei¹,He Shuang¹,Wu Dongming¹,Xu Ying¹

Affiliation:

1. College of Laboratory Medicine, Chengdu Medical College, Chengdu, Sichuan 610500, P.R. China

2. Clinical Laboratory, The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan 610500, P.R. China

3. Clinical Laboratory, Xindu District People's Hospital of Chengdu, Chengdu, Sichuan 610500, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Reference61 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung;CA Cancer J Clin,2021

2. Ubiquitin ligase CHAF1B induces cisplatin resistance in lung adenocarcinoma by promoting NCOR2 degradation;Gong;Cancer Cell Int,2020

3. Inherited rare, deleterious variants in ATM increase lung adenocarcinoma risk;Esai Selvan;J Thorac Oncol,2020

4. MiR-629-5p promotes the invasion of lung adenocarcinoma via increasing both tumor cell invasion and endothelial cell permeability;Li;Oncogene,2020

5. Pharmacogenomics of cisplatin sensitivity in non-small cell lung cancer;Rose;Genomics Proteomics Bioinformatics,2014

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developing a prognostic model using machine learning for disulfidptosis related lncRNA in lung adenocarcinoma;Scientific Reports;2024-06-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3